Banner

Autoimmune Disease Diagnosis Market 2022 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests), And By Region, Opportunities And Strategies – Global Forecast To 2031

Starting Price : $5000.00 $3350.00 | Pages : 273 | Published : June 2022 | SKU CODE : o&s479 | | Format :

Request Sample

Autoimmune Disease Diagnosis Market Definition

The autoimmune disease diagnosis consists of sales of diagnostic tests and related services by entities (organizations, sole traders and partnerships) that are used for the diagnosis of autoimmune diseases. Autoimmune diseases are the diseases in which the production of antibodies takes place in the body which attack and destroy the patient’s own healthy cells in the body. These include Crohn's disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus and inflammatory bowel syndrome, and are diagnosed by immunological tests.

Autoimmune Disease Diagnosis Market Size

The global autoimmune disease diagnosis market reached a value of nearly $4,773.9 million in 2021, having increased at a compound annual growth rate (CAGR) of 7.7% since 2016. The global autoimmune disease diagnosis market size is expected to grow from $4,773.9 million in 2021 to $6,982.7 million in 2026 at a rate of 7.9%. The global autoimmune disease diagnosis market size is then expected to grow at a CAGR of 8.2% from 2026 and reach $10,344.5 million in 2031.

Growth in the historic period resulted from rising incidence of autoimmune diseases, emerging markets growth, increased healthcare expenditure, and high prevalence in women. Factors that negatively affected growth in the historic period were the high costs, low healthcare reimbursements, COVID-19 pandemic, and complexity of diagnosis and lack of treatment options.

Going forward, increased funding for autoimmune (AI) diagnostics, faster economic growth, growing awareness about autoimmune diseases, and biomarker discovery will drive market growth. Factors that could hinder the growth of the autoimmune disease diagnosis market in the future include a rise in interest rates, lack of healthcare infrastructure, and stringent regulatory guidelines for the approval of medical devices.

Autoimmune Disease Diagnosis Market Drivers

The key drivers of the autoimmune disease diagnosis market include:

Increased Funding For Autoimmune (AI) Diagnostics

The increased funding for autoimmune diagnostics during the forecast period drives the autoimmune disease diagnosis market. Funding in the sector supports major companies expand their geographic footprint, strengthening their product portfolio, and helping increase research and development (R&D) activities. Investment and funds also help SMEs and start-ups in developing their drugs, and diagnostics and further expand the services offered. For instance, in 2022, The Lupus Foundation of America (LFA) had announced they had received a new grant from the Office of Minority Health (OMH) at the U.S. Department of Health and Human Services to support the substantial disparities in lupus clinical trial participation. Furthermore, in 2022, Scipher Medicine, a Massachusetts-based, autoimmune-focused biotech startup raised $110 million in a round led by Cowen Healthcare Investments, bringing Scipher’s total fundraising to $227 million. Moreover, in 2021, SQI Diagnostics, a precision medicine company developing diagnostic testing targeting organ transplants, autoimmune diseases, and more received $2.3 million in funds.

Biomarker Discovery

The discovery of biomarker is a key factor driving the growth of the market in the forecast period. A biomarker refers to a biological molecule present in blood, other bodily fluids, or tissues that indicates if a process is normal or aberrant, or whether a condition or illness exists. A biomarker can be used to determine how effectively the body reacts to an illness or condition's therapy. Also known as a signature molecule or a molecular marker. Biomarkers can be utilized to improve the efficacy and safety of already available drugs as well as to create novel ones. For instance, in May 2022, Sengenics has announced the debut of a new autoantibody profiling service called the 'Pan-Autoimmune Protein Array 1.0,' which will make it easier to find and quantify autoantibody disease biomarker patterns. Sengenics' KREX® protein folding technology and enhanced computational analysis are used in this multiplexed immunoassay based on protein microarrays. The protein microarray has 110 autoantigens that have been linked to a variety of autoimmune disorders in the literature. Researchers interested in investigating novel autoantibody signatures in particular autoimmune disorders, as well as those interested in researching the interaction between autoimmune diseases and tumors, will find this specialized material to be a cost- and time-effective, quantitative solution.

Autoimmune Disease Diagnosis Market Restraints

The key restraints on the autoimmune disease diagnosis market include:

Rise In Interest Rates

Interest rates globally are forecasted to rise in most of the developing and developed economies, during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise up to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the market growth.

Autoimmune Disease Diagnosis Market Trends

Major trends shaping the autoimmune disease diagnosis market include:

Use Of Artificial Intelligence

Artificial Intelligence is being increasingly incorporated with rapid diagnostic test kits to increase the efficiency of diagnosis. Artificial intelligence (AI) refers to the simulation of human intelligence in computer-controlled machines that are programmed to perform tasks, which usually require human intelligence. Artificial Intelligence algorithms are being used to integrate the findings of clinical symptoms, family history, and laboratory testing to increase the chance of early detection of autoimmune diseases. For instance, In March 2022, ImmuneID, a US-based immunology company had partnerships with two world-class healthcare research organizations, Icahn School of Medicine at Mount Sinai and University Hospital Erlangen. Both collaborations will use ImmuneID's aiSPIRE technology to demonstrate its potential to identify highly specific patient and population insights, as well as precisely segment patient subgroups, by screening huge numbers of peptide-antibody interactions and employing artificial intelligence (AI) to reveal immune system exposures and reactions. ImmuneID will use these new insights to develop target identification and precision therapeutics for the most difficult circumstances in autoimmunity and other critical illnesses.

Collaborations Between Governments And Manufacturers

Autoimmune diseases diagnostic manufacturers are increasingly entering into agreements with governments for mutual benefits. According to the American Autoimmune Related Diseases Association (AARDA), over 50 million Americans have been diagnosed with autoimmune illnesses, and this number is expected to rise in the future years. The global incidence of systemic and localized autoimmune illnesses, as well as the advent of numerous government programs and increased capacity to spend on the treatment of these conditions, will drive the autoimmune disease diagnostics market. Moreover, a number of government bodies, as well as non-governmental organizations, are sponsoring a variety of projects aimed at developing innovative therapies. For example, in 2021, the Accelerating Medicines Cooperation (AMP) established the RA/SLE ( Rheumatoid Arthritis and Systemic Lupus Erythematosus) Program in 2021, which is a public-private partnership involving the National Institutes of Health (NIH), the US Food and Drug Administration (FDA), and numerous non-profit organizations. The program's goal is to find pharmacological targets that can be used to treat autoimmune disorders.

Opportunities And Recommendations In The Autoimmune Disease Diagnosis Market

Opportunities –The top opportunities in the autoimmune disease diagnosis market by product will arise in the consumables and assay kits market, which will gain $1,297.6 million of global annual sales by 2026. The top opportunities in the autoimmune disease diagnosis market by end user will arise in the clinical laboratories market, which will gain $1,065.7 million of global annual sales by 2026. The top opportunities in the autoimmune disease diagnosis market by test type will arise in the immunologic tests market, which will gain $863.4 million of global annual sales by 2026. The autoimmune disease diagnosis market size will gain the most in the USA at $740.5 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the autoimmune disease diagnosis companies to focus on disposable diagnostic products, develop at-home test kits, use artificial intelligence, expand in emerging markets, provide at-home sample collection services, provide competitively priced offerings in low-income countries, focus on increasing awareness, leverage social media to maximize reach, conduct informative seminars and fairs, focus on priority to critical cases, target the older population and focus on hospitals and other diagnostic centers.

Autoimmune Disease Diagnosis Market Segmentation

The autoimmune disease diagnosis market is segmented by product, by end-user and by test type.
By Product –
he autoimmune disease diagnosis market is segmented by product into
    • a) Consumables
    • b) Assay Kits
The consumables and assay kits were the largest segment of the autoimmune disease diagnosis market by product, accounting for $2,642.4 million or 55.4% of the total market in 2021. It is expected to be the fastest-growing segment going forward at a CAGR of 8.3%.
By End User-
The autoimmune disease diagnosis market is segmented by end user
    • a) Clinical Laboratories
    • b) Hospitals
    • c) Others
The clinical laboratories market was the largest segment of the autoimmune disease diagnosis market by end user, accounting for $2,147.5 million or 45.0% of the total market in 2021. It is expected to be the fastest-growing segment going forward at a CAGR of 8.4%.
By Test Type –
The autoimmune disease diagnosis market is segmented by test type
    • d) Routine Laboratory Tests
    • e) Autoantibodies Tests
    • f) Immunologic Tests
    • g) Other Tests
The routine laboratory tests market was the largest segment of the autoimmune disease diagnosis market by test type, accounting for $1,778.1 million or 37.2% of the total market in 2021. The immunologic tests market is expected to be the fastest-growing segment going forward at a CAGR of 8.6%.
By Geography - The autoimmune disease diagnosis is segment by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the autoimmune disease diagnosis market, accounting for 36.8% of the global market in 2021. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the autoimmune disease diagnosis market will be Asia Pacific and the Western Europe, where growth will be at CAGRs of 8.41% and 8.37% respectively from 2021-2026.

Autoimmune Disease Diagnosis Market Competitive Landscape

Major Competitors are:

  • Siemens Healthineers AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Other Competitors Include:

  • Danaher Corporation
  • AESKU Diagnostics GmbH & Co. KG
  • Trinity Biotech plc.
  • bioMérieux SA
  • SQI Diagnostics
  • SCHILLER Healthcare India Pvt. Ltd
  • Covidien Healthcare India Private Limited
  • Philips Healthcare India
  • Fisher & Paykel Healthcare India Private Limited
  • Smith’s Medical India Pvt Ltd
  • Agappe Diagnostics Ltd
  • Accord Medical Products Private Limited
  • Terumo Corporation
  • Olympus Medical Systems Corporation
  • Canon Medical Systems Corporation
  • Hitachi Group
  • Nihon Koden Corporation
  • Sanko Manufacturing Co.,Ltd
  • Fukuda Denshi
  • Metran Co., Ltd
  • Shinva Medical Instrument Company Limited
  • Shandong WeiGao Group Medical Polymer Company Limited
  • Lepu Medical Technology Company (Beijing) Co., Ltd
  • Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd
  • Shanghai Runda Medical Technology Co., Ltd
  • GE Healthcare China Co., Ltd
  • Smiths Medical (Beijing) Co., Ltd
  • Roche Holding AG
  • Siemens AG
  • Koninklijke Philips
  • Theradiag
  • Sanofi
  • B. Braun(Germany)
  • Fresenius Medical Care
  • Novartis
  • Merck
  • Bayer
  • Medtronic
  • Draegerwerk AG
  • Getinge Group
  • Themis Bioscience
  • Stryker
  • Apotex
  • Bausch Health
  • Pfizer
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • HYCOR Biomedical
  • Exagen Inc
  • Kronus
  • Inova Diagnostics
  • Masimo
  • Teleflex Inc
  • 3M
  • Johnson & Johnson
  • Becton Dickinson
  • B. Braun Medical Inc
  • ResMed Inc
    1. Table Of Contents

      1. Autoimmune Disease Diagnosis Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1.1. Segmentation By Geography

      6.1.2. Segmentation By Product

      6.1.3. Segmentation By End-User

      6.1.4. Segmentation By Test Type

      7. Autoimmune Disease Diagnosis Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Product

      7.2.1. Consumables And Assay Kits

      7.2.2. Instruments

      7.3. Segmentation By Test Type

      7.3.1. Routine Laboratory Tests

      7.3.2. Autoantibodies Tests

      7.3.3. Immunologic Tests

      7.3.4. Other Tests

      7.4. Segmentation By End User

      7.4.1. Clinical Laboratories

      7.4.2. Hospitals

      7.4.3. Others

      8. Autoimmune Disease Diagnosis Market Trends

      8.1. Strategic Partnerships and Acquisitions

      8.2. Use Of Artificial Intelligence

      8.3. Collaborations Between Governments And Manufacturers

      8.4. At-Home Test Kits

      8.5. Supportive Government Funding and Initiatives

      9. Impact Of COVID-19 On Autoimmune Disease Diagnosis Market

      9.1. Introduction

      9.2. COVID-19 and Autoimmune Diseases

      9.3. Disruption To The Supply Chain

      9.4. Future Outlook

      10. Global Autoimmune Disease Diagnosis Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      10.2.1. Drivers Of the Market 2016 – 2021

      10.2.2. Emerging Markets Growth

      10.2.3. Restraints On the Market 2016 – 2021

      10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      10.3.1. Drivers Of The Market 2021 – 2026

      10.3.2. Restraints On The Market 2021 – 2026

      11. Global Autoimmune Disease Diagnosis Market Segmentation

      11.1. Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.2. Global Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.3. Global Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Autoimmune Disease Diagnosis Market, Regional And Country Analysis

      12.1. Global Autoimmune Disease Diagnosis Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.2. Global Autoimmune Disease Diagnosis Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Asia-Pacific Autoimmune Disease Diagnosis Market

      13.1. Asia-Pacific Autoimmune Disease Diagnosis Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulatory Bodies

      13.1.6. Regulations

      13.1.7. Taxes Levied

      13.1.8. Corporate Tax Structure

      13.1.9. Major Associations

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.3. Asia-Pacific Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.4. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.5. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. Asia-Pacific Autoimmune Disease Diagnosis Market: Country Analysis

      13.7. China Autoimmune Disease Diagnosis Market

      13.8. China Autoimmune Disease Diagnosis Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. Background Information

      13.8.4. Government Initiatives

      13.8.5. Regulatory Bodies

      13.8.6. Regulations

      13.8.7. Major Associations

      13.8.8. Taxes Levied

      13.8.9. Corporate Tax Structure

      13.8.10. Investments

      13.8.11. Major Companies

      13.9. China Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.10. China Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.11. China Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.12. China Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.13. India Autoimmune Disease Diagnosis Market

      13.14. India Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.15. India Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.16. India Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.17. India Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.18. Japan Autoimmune Disease Diagnosis Market

      13.19. Japan Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.20. Japan Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.21. Japan Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.22. Japan Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.23. Australia Autoimmune Disease Diagnosis Market

      13.24. Australia Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.25. Australia Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.26. Australia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.27. Australia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.28. Indonesia Autoimmune Disease Diagnosis Market

      13.29. Indonesia Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.30. Indonesia Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.31. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.32. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.33. South Korea Autoimmune Disease Diagnosis Market

      13.34. South Korea Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.35. South Korea Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.36. South Korea Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.37. South Korea Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. Western Europe Autoimmune Disease Diagnosis Market

      14.1. Western Europe Autoimmune Disease Diagnosis Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background information

      14.1.4. Government Initiatives

      14.1.5. Regulatory Bodies

      14.1.6. Regulations

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.3. Western Europe Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.4. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.5. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. Western Europe Autoimmune Disease Diagnosis Market: Country Analysis

      14.7. UK Autoimmune Disease Diagnosis Market

      14.8. UK Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.9. UK Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.10. UK Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.11. UK Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.12. Germany Autoimmune Disease Diagnosis Market

      14.13. Germany Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.14. Germany Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.15. Germany Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.16. Germany Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.17. France Autoimmune Disease Diagnosis Market

      14.18. France Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.19. France Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.20. France Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.21. France Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. Eastern Europe Autoimmune Disease Diagnosis Market

      15.1. Eastern Europe Autoimmune Disease Diagnosis Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulatory Bodies

      15.1.6. Regulations

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.3. Eastern Europe Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.4. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.5. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. Eastern Europe Autoimmune Disease Diagnosis Market: Country Analysis

      15.7. Russia Autoimmune Disease Diagnosis Market

      15.8. Russia Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.9. Russia Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.10. Russia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.11. Russia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. North America Autoimmune Disease Diagnosis Market

      16.1. North America Autoimmune Disease Diagnosis Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulatory Bodies

      16.1.6. Regulations

      16.1.7. Associations

      16.1.8. Corporate Tax Structure

      16.1.9. Investments

      16.1.10. Major Companies

      16.2. North America Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.3. North America Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.4. North America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.5. North America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. North America Autoimmune Disease Diagnosis Market: Country Analysis

      16.7. USA Autoimmune Disease Diagnosis Market

      16.8. USA Autoimmune Disease Diagnosis Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. Background Information

      16.8.4. Government Initiatives

      16.8.5. Regulatory Bodies

      16.8.6. Regulations

      16.8.7. Major Associations

      16.8.8. Taxes Levied

      16.8.9. Investments

      16.8.10. Major Companies

      16.9. USA Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.10. USA Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.11. USA Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.12. USA Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. South America Autoimmune Disease Diagnosis Market

      17.1. South America Autoimmune Disease Diagnosis Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulatory Bodies

      17.1.6. Regulations

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate tax structure

      17.1.10. Major Companies

      17.2. South America Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.3. South America Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.4. South America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.5. South America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.6. South America Autoimmune Disease Diagnosis Market: Country Analysis

      17.7. Brazil Autoimmune Disease Diagnosis Market

      17.8. Brazil Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.9. Brazil Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.10. Brazil Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.11. Brazil Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Middle East Autoimmune Disease Diagnosis Market

      18.1. Middle East Autoimmune Disease Diagnosis Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulatory Bodies

      18.1.6. Regulations

      18.1.7. Associations

      18.1.8. Taxes And Duties

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      18.3. Middle East Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      18.4. Middle East Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18.5. Middle East Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19. Africa Autoimmune Disease Diagnosis Market

      19.1. Africa Autoimmune Disease Diagnosis Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background information

      19.1.4. Government Initiatives

      19.1.5. Regulatory Bodies

      19.1.6. Regulations

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Autoimmune Disease Diagnosis Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      19.3. Africa Autoimmune Disease Diagnosis Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      19.4. Africa Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19.5. Africa Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      20. Autoimmune Disease Diagnosis Market Competitive Landscape And Company Profiles

      21. Company Profiles

      21.1. Siemens Healthineers

      21.1.1. Company Overview

      21.1.2. Products And Services

      21.1.3. Business Strategy

      21.1.4. Financial Overview

      21.2. Abbott Laboratories

      21.2.1. Company Overview

      21.2.2. Products And Services

      21.2.3. Financial Overview

      21.3. Thermo Fisher Scientific Inc.

      21.3.1. Company Overview

      21.3.2. Products And Services

      21.3.3. Business Strategy

      21.3.4. Financial Overview

      21.4. Bio-Rad Laboratories Inc.

      21.4.1. Company Overview

      21.4.2. Products And Services

      21.4.3. Business Strategy

      21.4.4. Financial Overview

      21.5. F. Hoffmann-La Roche AG

      21.5.1. Company Overview

      21.5.2. Products And Services

      21.5.3. Business Strategy

      21.5.4. Financial Overview

      22. Key Mergers And Acquisitions In The Autoimmune Disease Diagnosis Market

      22.1. Quest Diagnostics Acquires Labtech Diagnostics

      22.2. Merck Acquires Chord Therapeutics

      22.3. Labcorp Acquires Assets of Myriad Genetics

      22.4. Sebia Acquires ORGENTEC Diagnostika

      22.5. Merck & Co. Acquired Pandion Therapeutics

      22.6. Bio-Rad Laboratories Acquires Celsee

      22.7. AESKU.GROUP Acquires MBL BION

      22.8. Oncimmune Acquires Protagen Diagnostics

      22.9. PerkinElmer Acquires Euroimmune

      23. Autoimmune Disease Diagnosis Market Opportunities And Strategies

      23.1. Global Autoimmune Disease Diagnosis Market In 2026 – Countries Offering Most New Opportunities

      23.2. Global Autoimmune Disease Diagnosis Market In 2026 – Segments Offering Most New Opportunities

      23.3. Global Autoimmune Disease Diagnosis Market In 2026 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. Autoimmune Disease Diagnosis Market, Conclusions And Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2. Place

      24.2.3. Price

      24.2.4. Promotion

      24.2.5. People

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      25.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Autoimmune Disease Diagnosis Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Autoimmune Disease Diagnosis Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Autoimmune Disease Diagnosis Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Autoimmune Disease Diagnosis Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
    • Table 14: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 15:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 16: Asia Pacific Diabetes Prevalence Rate, 2015-2019,%
    • Table 17: Asia-Pacific Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 18: Asia-Pacific Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 19: Asia-Pacific Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 20: Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 21: Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 22: Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 23: Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 24: China Population By Age Group, 2016-2026, Thousands
    • Table 25:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 26: China Diabetes Prevalence Rate, 2015-2019,%
    • Table 27: Asia-Pacific Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 28: China Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 29: China Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 30: China Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 31: China Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 32: China Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 33: China Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 34: India Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 35: India Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 36: India Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 37: India Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 38: India Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 39: India Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 40: Japan Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 41: Japan Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 42: Japan Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 43: Japan Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 44: Japan Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 45: Japan Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 46: Australia Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 47: Australia Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 48: Australia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 49: Australia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 50: Australia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 51: Australia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 52: Indonesia Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 53: Indonesia Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 54: Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 55: Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 56: Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 57: Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 58: South Korea Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 59: South Korea Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 60: South Korea Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 61: South Korea Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 62: South Korea Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 63: South Korea Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 64: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 65:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 66:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 67: Western Europe Diabetes Prevalence Rate, 2015-2019,%
    • Table 68: Western Europe Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 69: Western Europe Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 70: Western Europe Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 71: Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 72: Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 73: Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 74: Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 75: UK Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 76: UK Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 77: UK Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 78: UK Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 79: UK Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 80: UK Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 81: Germany Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 82: Germany Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 83: Germany Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 84: Germany Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 85: Germany Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 86: Germany Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 87: France Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 88: France Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 89: France Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 90: France Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 91: France Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 92: France Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 93: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
    • Table 94:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 95:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 96: Eastern Europe Diabetes Prevalence Rate, 2015-2019,%
    • Table 97: Eastern Europe Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 98: Eastern Europe Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 99: Eastern Europe Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 100: Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 101: Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 102: Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 103: Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 104: Russia Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 105: Russia Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 106: Russia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 107: Russia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 108: Russia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 109: Russia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 110: North America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 111:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 112:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 113: North America Diabetes Prevalence Rate, 2015-2019,%
    • Table 114: North America Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 115: North America Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 116: North America Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 117: North America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 118: North America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 119: North America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 120: North America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 121: USA Population By Age Group, 2016-2026, Thousands
    • Table 122:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 123: USA Diabetes Prevalence Rate, 2015-2019,%
    • Table 124: USA Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 125: USA Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 126: USA Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 127: USA Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 128: USA Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 129: USA Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 130: USA Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 131: South America Population By Age Group, By Country, 2016-2026, Thousands
    • Table 132:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 133:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 134: South America Diabetes Prevalence Rate, 2015-2019,%
    • Table 135: South America Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 136: South America Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 137: South America Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 138: South America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 139: South America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 140: South America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 141: South America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 142: Brazil Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 143: Brazil Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 144: Brazil Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 145: Brazil Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 146: Brazil Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 147: Brazil Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 148: Middle East Population By Age Group, By Country, 2016-2026, Thousands
    • Table 149:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 150:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 151: Middle East Diabetes Prevalence Rate, 2015-2019,%
    • Table 152: Middle East Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 153: Middle East Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 154: Middle East Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 155: Middle East Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 156: Middle East Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 157: Middle East Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 158: Middle East Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 159: Africa Population By Age Group, By Country, 2016-2026, Thousands
    • Table 160:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
    • Table 161:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
    • Table 162: Africa Diabetes Prevalence Rate, 2015-2019,%
    • Table 163: Africa Prevalence Of Multiple Sclerosis, 2015-2019, Number
    • Table 164: Africa Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Table 165: Africa Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 166: Africa Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 167: Africa Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 168: Africa Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 169: Africa Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 170: Global Autoimmune Disease Diagnosis Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Table 171: Siemens Healthineers – Financial Performance, $ Billion
    • Table 172: Abbott – Financial Performance, $ Billion
    • Table 173: Thermo Fisher– Financial Performance, $ Billion
    • Table 174: Bio-Rad – Financial Performance, $ Billion
    • Table 175: Roche – Financial Performance, $ Billion
    • Table 176: Global Autoimmune Disease Diagnosis Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 177: Global Autoimmune Disease Diagnosis Market Size Gain ($ Million), Segmentation By Product, 2021 – 2026
    • Table 178: Global Autoimmune Disease Diagnosis Market Size Gain ($ Million), Segmentation By End-User, 2021 – 2026
    • Table 179: Global Autoimmune Disease Diagnosis Market Size Gain ($ Million), Segmentation By Test Type, 2021 – 2026
    • Table 180: Autoimmune Disease Diagnosis- Market Data Sources

    List Of Figures

      Figure 1: Global Autoimmune Disease Diagnosis Market Segmentation By Product
    • Figure 2: Global Autoimmune Disease Diagnosis Market Segmentation By End-User
    • Figure 3: Global Autoimmune Disease Diagnosis Market Segmentation By Test Type
    • Figure 4: Global Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 5: Global Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 6: Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 7: Global Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 8: Global Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 9: Global Autoimmune Disease Diagnosis Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 10: Global Autoimmune Disease Diagnosis Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 11: Asia-Pacific Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 12: Asia-Pacific Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 13: Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 14: Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 15: China Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 16: China Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 17: China Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 18: China Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 19: India Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 20: India Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 21: India Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 22: India Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 23: Japan Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 24: Japan Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 25: Japan Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 26: Japan Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 27: Australia Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 28: Australia Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 29: Australia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 30: Australia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 31: Indonesia Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 32: Indonesia Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 33: Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 34: Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 35: South Korea Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 36: South Korea Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 37: South Korea Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 38: South Korea Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 39: Western Europe Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 40: Western Europe Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 41: Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 42: Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 43: UK Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 44: UK Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 45: UK Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 46: UK Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 47: Germany Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 48: Germany Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 49: Germany Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 50: Germany Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 51: France Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 52: France Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 53: France Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 54: France Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 55: Eastern Europe Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 56: Eastern Europe Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 57: Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 58: Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 59: Russia Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 60: Russia Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 61: Russia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 62: Russia Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 63: North America Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 64: North America Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 65: North America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 66: North America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 67: USA Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 68: USA Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 69: USA Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 70: USA Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 71: South America Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 72: South America Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 73: South America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 74: South America Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 75: Brazil Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 76: Brazil Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 77: Brazil Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 78: Brazil Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 79: Middle East Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 80: Middle East Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 81: Middle East Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 82: Middle East Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 83: Africa Autoimmune Disease Diagnosis Market, Historic, 2016 – 2021, $ Million
    • Figure 84: Africa Autoimmune Disease Diagnosis Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 85: Africa Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 86: Africa Autoimmune Disease Diagnosis Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 87: Global Autoimmune Disease Diagnosis Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)
    • Figure 88: Siemens Healthineers– Financial Performance, $ Billion
    • Figure 89: Abbott – Financial Performance, $ Billion
    • Figure 90: Thermo Fisher– Financial Performance, $ Billion
    • Figure 91: Bio-Rad – Financial Performance, $ Billion
    • Figure 92: Roche – Financial Performance, $ Billion
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
    The Aesthetic Medicine Market Share, Market Size, And Growth Rate 2022
    The Leukemia Therapeutics Market Share, Market Size, And Growth Rate 2022
    How Will The Medical Foods Market Grow In 2022?
    How Will The Filgrastim Biosimilar Market Grow In 2022?
    The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
    The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
    Vaccines Market 2021 - By Type (Anti-Infective Vaccines, Anti-Cancer Vaccines, Others), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Other Route of Administration), By Valance (Monovalent, Multivalent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Enzymes Global Market Report 2022 – By Product Type (Asparginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Protein Inhibitors Global Market Report 2022 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody), By Application (Oncology, Inflamatory Diseases), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Microbiome Global Market Report 2022 – By Type (Fecal Microbiota Transplantation (FMT), Microbiome drugs), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis), By Technology (Genomics, Proteomics, Metabolomics) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Cellular Immunotherapy Global Market Report 2022 – By Therapy (Tumour-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumour, Lung Cancer) – Market Size, Trends, And Global Forecast 2022-2026
    View Report
    Digestive Enzymes Global Market Report 2022 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2022-2026
    View Report